Trial Profile
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2021
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary) ; Aflibercept
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms TYBEE
- Sponsors Clearside Biomedical
- 23 Sep 2020 According to an Clearside Biomedical media release, data from this study was published in Ophthalmology Retina.
- 23 Sep 2020 Results published in the Clearside Biomedical Media Release.
- 25 Feb 2020 Results published in the Clearside Biomedical Media Release.